148 related articles for article (PubMed ID: 23913246)
21. Effects of intravitreal injection of human CD34
Yazdanyar A; Zhang P; Dolf C; Smit-McBride Z; Cary W; Nolta JA; Zawadzki RJ; Marsh-Armstrong N; Park SS
Exp Eye Res; 2020 Jan; 190():107865. PubMed ID: 31682846
[TBL] [Abstract][Full Text] [Related]
22. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
23. A central role for inflammation in the pathogenesis of diabetic retinopathy.
Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP
FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732
[TBL] [Abstract][Full Text] [Related]
24. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
25. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.
Muir ER; Rentería RC; Duong TQ
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034
[TBL] [Abstract][Full Text] [Related]
26. Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse.
Hombrebueno JR; Ali IH; Xu H; Chen M
Sci Rep; 2015 Dec; 5():18316. PubMed ID: 26671074
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
28. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2
Elshaer SL; Evans W; Pentecost M; Lenin R; Periasamy R; Jha KA; Alli S; Gentry J; Thomas SM; Sohl N; Gangaraju R
Stem Cell Res Ther; 2018 Nov; 9(1):322. PubMed ID: 30463601
[TBL] [Abstract][Full Text] [Related]
29. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
[TBL] [Abstract][Full Text] [Related]
30. Retinal changes in mice spontaneously developing diabetes by Th17-cell deviation.
Taguchi M; Someya H; Inada M; Nishio Y; Takayama K; Harimoto K; Karasawa Y; Ito M; Takeuchi M
Exp Eye Res; 2020 Sep; 198():108155. PubMed ID: 32717339
[TBL] [Abstract][Full Text] [Related]
31. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
32. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.
Shen WY; Lai CM; Graham CE; Binz N; Lai YK; Eade J; Guidolin D; Ribatti D; Dunlop SA; Rakoczy PE
Diabetologia; 2006 Jul; 49(7):1690-701. PubMed ID: 16752188
[TBL] [Abstract][Full Text] [Related]
33. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
[TBL] [Abstract][Full Text] [Related]
34. Endothelial Toll-like receptor 4 is required for microglia activation in the murine retina after systemic lipopolysaccharide exposure.
Tsioti I; Steiner BL; Escher P; Zinkernagel MS; Benz PM; Kokona D
J Neuroinflammation; 2023 Feb; 20(1):25. PubMed ID: 36739425
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
36. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation.
Kubota S; Kurihara T; Mochimaru H; Satofuka S; Noda K; Ozawa Y; Oike Y; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3512-9. PubMed ID: 19279313
[TBL] [Abstract][Full Text] [Related]
37. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
38. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
[TBL] [Abstract][Full Text] [Related]
39. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
40. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA
Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
